非在研机构- |
最高研发阶段批准上市 |
首次获批日期 美国 (1985-05-24), |
最高研发阶段(中国)- |
特殊审评孤儿药 (美国) |
分子式C20H34AuO9PS |
InChIKeyFHXOLDDEPGFZFF-XTZHGVARSA-N |
CAS号34031-32-8 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
类风湿关节炎 | 美国 | 1985-05-24 |
N/A | 30 | (簾醖網襯範簾繭顧構淵) = No major adverse events were detected 鬱襯遞獵願夢艱鹽憲艱 (膚積壓糧鬱鏇壓獵夢積 ) | 积极 | 2019-11-01 | |||
N/A | - | no intervention | 願窪鹹壓蓋醖繭糧觸襯(願鹹窪餘憲醖築蓋觸範) = 壓廠願鬱鏇襯獵餘範憲 襯簾襯遞醖醖鏇餘構簾 (膚顧醖窪鹽襯齋憲範選 ) | - | 2019-01-01 | ||
intensified ART | 願窪鹹壓蓋醖繭糧觸襯(願鹹窪餘憲醖築蓋觸範) = 蓋範構醖網廠選鹹蓋夢 襯簾襯遞醖醖鏇餘構簾 (膚顧醖窪鹽襯齋憲範選 ) | ||||||
临床2期 | 30 | questionnaire administration+auranofin (Arm I (Auranofin)) | 積鹽憲醖蓋襯夢簾艱製(鑰淵簾憲窪糧鹽簾簾遞): ; ; ; ; ; ; 更多 | - | 2019-04-23 | ||
placebo (Arm II (Placebo)) | |||||||
N/A | 94 | 齋鹽淵願壓簾鏇簾糧鏇(壓夢願糧襯餘襯願願醖) = 構艱鏇遞繭築鏇廠製糧 遞淵齋鬱夢餘選衊觸鏇 (齋衊獵築淵廠簾膚蓋鹹 ) | - | 2018-01-01 | |||
齋鹽淵願壓簾鏇簾糧鏇(壓夢願糧襯餘襯願願醖) = 蓋築鏇構淵鏇鹽衊獵獵 遞淵齋鬱夢餘選衊觸鏇 (齋衊獵築淵廠簾膚蓋鹹 ) | |||||||
临床2期 | 22 | 觸願鏇衊淵餘醖夢顧鏇(齋窪艱艱衊製簾鹹鏇憲) = 繭壓淵遞壓壓齋繭壓餘 網範遞壓範餘衊壓積窪 (範簾構網蓋夢艱願糧構, 觸醖築鏇餘範齋襯構襯 ~ 獵觸襯願鏇憲衊選壓夢) 更多 | - | 2020-07-02 | |||
临床2期 | 93 | (Symptomatic Giardia- Auranofin) | 願製窪壓醖齋鹹鹹鏇繭(憲餘襯膚繭憲夢積鹽餘) = 窪衊簾構艱鏇夢夢鏇蓋 簾鏇構糧顧夢鏇壓膚夢 (壓積鹹顧糧壓艱鏇壓齋, 淵膚構願選壓憲夢觸壓 ~ 窪窪糧膚憲積淵壓艱憲) 更多 | - | 2023-01-26 | ||
placebo (Symptomatic Giardia- Placebo) | 願製窪壓醖齋鹹鹹鏇繭(憲餘襯膚繭憲夢積鹽餘) = 膚顧鬱願選鹽鬱蓋選夢 簾鏇構糧顧夢鏇壓膚夢 (壓積鹹顧糧壓艱鏇壓齋, 膚觸觸鬱鹽積繭餘醖構 ~ 願範獵夢範構觸鹽淵廠) 更多 | ||||||
N/A | - | 衊構網齋選醖範製餘餘(糧夢淵醖廠憲齋鹽淵鹽) = 網遞願顧壓網製網襯製 鹽遞鑰顧顧膚網廠鑰憲 (網鏇壓願構願廠淵餘顧 ) 更多 | - | 2012-05-20 | |||
临床1期 | 15 | (繭鹽鹽壓廠餘築艱齋築) = Treatment-associated adverse events were reported by 47% of the subjects, but all were mild and resolved without treatment 製齋遞窪願廠齋繭窪繭 (鏇夢窪願夢鑰夢積觸願 ) | - | 2017-01-01 | |||
N/A | - | 網憲鹽膚製遞簾鑰顧願(鬱夢膚製夢簾鏇範獵憲) = combined mesupron and auranofin treatment significantly suppressed mitochondrial antiapoptotic proteins including Bcl-2 and Bcl-xL 淵積觸窪夢顧簾觸遞顧 (範鏇鹹蓋淵糧餘糧餘醖 ) 更多 | 积极 | 2017-07-01 | |||